Eidos Therapeutics Inc (OQ:EIDX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Dec 10/18 Dec 7/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 4,860 $14.36
Dec 10/18 Dec 7/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 36,314 $13.94
Dec 10/18 Dec 6/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 38,970 $13.34
Dec 6/18 Dec 5/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 1,103,848 $14.01
Dec 7/18 Dec 4/18 Lis William Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Dec 6/18 Dec 3/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 1,750,000 $15.50
Nov 7/18 Nov 7/18 Turtle Cameron Direct Ownership Stock Option (right to buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 7/18 Nov 7/18 Turtle Cameron Direct Ownership Stock Option (right to buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 7/18 Nov 7/18 Turtle Cameron Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 7/18 Nov 5/18 Siu Christine Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Dec 10/18 Dec 7/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 4,860 $14.36
Dec 10/18 Dec 7/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 36,314 $13.94
Dec 10/18 Dec 6/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 38,970 $13.34
Dec 7/18 Dec 4/18 Lis William Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Dec 6/18 Dec 5/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 1,103,848 $14.01
Dec 6/18 Dec 3/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 1,750,000 $15.50
Nov 7/18 Nov 5/18 Siu Christine Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Nov 7/18 Nov 5/18 Fox Jonathan C Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 70,000  
Nov 7/18 Nov 5/18 Sinha Uma Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 60,000  
Nov 7/18 Nov 7/18 Turtle Cameron Direct Ownership Stock Option (right to buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EIDX

StockTwits